- PA1-139 - Invitrogen Antibodies PPP1R15A antibody

Submitted references Inhibition of eIF2α Phosphorylation by Peste des Petits Ruminant Virus Phosphoprotein Facilitates Viral Replication.

Alfred N, Qian B, Qin X, Yin X, Prajapati M, Dou Y, Li Y, Zhang Z
Frontiers in veterinary science 2021;8:645571

GADD34 is a modulator of autophagy during starvation.

Gambardella G, Staiano L, Moretti MN, De Cegli R, Fagnocchi L, Di Tullio G, Polletti S, Braccia C, Armirotti A, Zippo A, Ballabio A, De Matteis MA, di Bernardo D
Science advances 2020 Sep;6(39)

Raloxifene prevents stress granule dissolution, impairs translational control and promotes cell death during hypoxia in glioblastoma cells.

Attwood KM, Robichaud A, Westhaver LP, Castle EL, Brandman DM, Balgi AD, Roberge M, Colp P, Croul S, Kim I, McCormick C, Corcoran JA, Weeks A
Cell death & disease 2020 Nov 17;11(11):989

Mytych J, Sołek P, Będzińska A, Rusinek K, Warzybok A, Tabęcka-Łonczyńska A, Koziorowski M
Cells 2020 Jan 21;9(2)

EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC.

Krishnamoorthy GP, Davidson NR, Leach SD, Zhao Z, Lowe SW, Lee G, Landa I, Nagarajah J, Saqcena M, Singh K, Wendel HG, Dogan S, Tamarapu PP, Blenis J, Ghossein RA, Knauf JA, Rätsch G, Fagin JA
Cancer discovery 2019 Feb;9(2):264-281

Heterozygous Truncating Variants in POMP Escape Nonsense-Mediated Decay and Cause a Unique Immune Dysregulatory Syndrome.

Poli MC, Ebstein F, Nicholas SK, de Guzman MM, Forbes LR, Chinn IK, Mace EM, Vogel TP, Carisey AF, Benavides F, Coban-Akdemir ZH, Gibbs RA, Jhangiani SN, Muzny DM, Carvalho CMB, Schady DA, Jain M, Rosenfeld JA, Emrick L, Lewis RA, Lee B, Undiagnosed Diseases Network members, Zieba BA, Küry S, Krüger E, Lupski JR, Bostwick BL, Orange JS
American journal of human genetics 2018 Jun 7;102(6):1126-1142

No comments: Submit comment

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescent analysis of GADD34 (green) in HeLa cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 5% normal goat serum (Product # 31873) for 15 minutes at room temperature. Cells were probed with a GADD34 polyclonal antibody (Product # PA1-139) at a dilution of 1:50 for at least 1 hour at room temperature, washed with PBS, and incubated with DyLight 488 goat anti-rabbit IgG secondary antibody (Product # 35552) at a dilution of 1:500 for 30 minutes at room temperature. F-actin (red) was stained with DyLight 650 Phalloidin (Product # 21838) and nuclei (blue) were stained with Hoechst 33342 dye (Product # 62249). Images were taken on a Thermo Scientific ArrayScan or ToxInsight Instrument at 20X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Fig. 5 Raloxifene delays resumption of protein translation post-hypoxia in correlation with increased eIF2alpha phosphorylation and decreased mTOR signaling. A and B Puromycin incorporation assay. U251 cells were treated with 40 muM raloxifene or DMSO vehicle control for 1 h prior to 2 h hypoxic A or non-hypoxic B incubation. At various times post-hypoxic or normoxic incubation cells were treated with 10 mug/mL puromycin for 10 min and puromycin incorporation into nascent proteins was detected by anti-puromycin blot. Blots were normalized to total lane protein, and represented as ratios with DMSO time 0 normalized to 1 (bottom quantification panels). Data is presented as the mean of triplicates +- SEM, unpaired t -test * p < 0.05; ** p < 0.01. C and D U251 cells were treated as in A but without addition of puromycin. Cell lysates were probed for eIF2alpha, phospho-eIF2alpha, GADD34, rpS6, and phospho-rpS6 at various times post-hypoxic C or normoxic D incubation. All blots were normalized to total lane protein with DMSO time 0 set to 1 (bottom quantification panels). The level of eIF2alpha phosphorylation is presented as the ratio of p-eIF2alpha to total eIF2alpha (bottom quantification panels). The level of rpS6 phosphorylation is similarly presented. Data is presented as the mean of triplicates +- SEM, unpaired t -test, and false discovery rate of 1%. * p < 0.05; ** p < 0.01.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 2 PPRV infection modulates GADD34 protein expression in Vero cells. Vero cells were infected with PPRV or mock-infected at indicated times. (A) The effect of PPRV on GADD34 protein expression was analyzed by Western blot. (B) Densitometry quantification of GADD34 was normalized to beta-actin and fold change was measured within each time point compared with mock-infected by ImageJ analysis. Statistical analysis was performed using GraphPad Prism 8 software. Shown are representative immunoblots and the error bars represent the mean +- SD from three independent experiments. Asterisks represent the statistically significant difference between mock and infected cells (*** P < 0.001 and ns, not significant). (C) Vero cells were infected with PPRV or mock-infected for 72 h. (D) Vero cells were transfected with Flag-GADD34 (12 h) before infection with PPRV or mock infection for a further 72 h. Cells were double-stained with mouse monoclonal antibodies against PPRV N protein (1:50) and Rabbit anti-GADD34 antibodies (PA1-139) 1:100 in (C) or Rabbit anti-Flag (ab1162) 1:200 in (D) as primary antibodies overnight. Goat anti-rabbit IgG (H&L) Alexa Fluor 488 (ab150077) Green1:500 and Goat anti-mouse IgG H&L (Alexa Fluor 647) (ab150115) Red 1:1000 were used as secondary antibodies for 1 h at room temperature. DAPI was used to stain the cell nuclei (blue).

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 3 PPRV infection represses ER stress-induced eIF2alpha phosphorylation in Vero cells. Vero cells were infected with PPRV or mock-infected. (A,C) PPRV infection represses eIF2alpha phosphorylation, induced by DTT and TG, respectively. PPRV-infected or mock-infected cells were treated with DTT (2 mM) or TG (1 muM) for 2 h (for DTT) or 12 h (for TG), respectively, to induce ER stress. The effect of PPRV on p-eIF2alpha and GADD34 expression in DTT- or TG-treated groups were analyzed by Western blot. (B,D) Densitometry quantification of p-eIF2alpha and GADD34 was normalized to beta-actin. Fold change was measured and compared with mock-infected treated or untreated by ImageJ analysis. Statistical analysis was performed using GraphPad Prism 8.0 software. Shown are representative immunoblots with the error bars representing the mean +- SD from three independent experiments. Asterisks represent statistically significant differences between treated and untreated groups (* P < 0.05; ** P < 0.01). # In the graphic (D) , plot 5 represents one set of untreated samples (lines 5 to 7) and plot 6 represents one set of TG-treated samples (lines 8 to 10).

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 4 Inhibition of eIF2alpha dephosphorylation is beneficial to PPRV replication. Vero cells were infected with PPRV or mock-infected. (A,C) After 2-h adsorption, infection media was replaced by fresh media treated with 5, 10, and 25 muM of Salubrinal in (A) or ISRIB (200 nM) in (C) and incubated up to 60 h.p.i. for Salubrinal and 48 h.p.i. for ISRIB. Treatment with DMSO alone was used as control. The effect of PPRV on p-eIF2alpha in treated or untreated groups were analyzed by Western blot. (B,D) Densitometry quantification of p-eIF2alpha, GADD34, and PPRV-N was normalized to beta-actin and fold change between treated and untreated was determined by ImageJ analysis. Statistical analysis was performed using GraphPad Prism 8.0 software. On the graphs, shown are representative immunoblots with the error bars representing the mean +- SD from three independent experiments. (E,F) RT-qPCR was used to quantify the mRNA levels of PPRV in samples treated or untreated with Salubrinal (E) or ISRIB (F) . Viral RNA of the positive control (PC) or vehicle treated with DMSO were compared to that of Salubrinal or ISRIB treated groups. The mean +- standard deviation (SD) was obtained in triplicate ( n = 3). Statistical analysis was performed using GraphPad Prism 8.0 software using multiple t -tests. Asterisks represent statistically significant differences between treated and untreated groups (* P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, not significant).

PA1-139

Antibody data